IMMUNOPATHOLOGY OF HIV-1 VPR
IMMUNOPATHOLOGY OF HIV-1 VPR
批准号:
7417646
负责人:
VELPANDI AYYAVOO
金额:
$36.21万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2009-05-31
关键词:
AddressAffectAntigen-Presenting CellsBindingCD28 geneCD80 geneCell CommunicationCell physiologyCellsCharacteristicsConsequences of HIVDendritic CellsDisease ProgressionDistalEquilibriumEventExposure toFunctional disorderGoalsHIV-1Immune System DiseasesImmune responseImmune systemImmunityIndividualInfectionMediatingMembraneMemoryMethodsMolecularMyelogenousNatural ImmunityNatural Killer CellsPathogenesisPeripheral Blood Mononuclear CellPhenotypePlayProcessProteinsPublishingReceptor SignalingRecombinantsReportingRoleSignal PathwaySignal TransductionSiteT-Cell ActivationT-LymphocyteThinkingViralViral ProteinsVirionVirusVirus Diseasesbasechemokinecytokinecytotoxicitydesignimmune functionimmunopathologyin vivointerestkillingsmonocytepathogenreceptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Presence of defective NK cells in HIV-1 individuals indicates that HIV-1 infection compromises the
nnate as well as the adaptive immune response. Though HIV-1 viral proteins are known to contribute to NK
cell dysfunction and innate immunity, the mechanism(s) by which these viral proteins impair NK cell function
is not well understood. We are particularly interested in the potential of HIV-1 Vpr, in immunopathogenesis
and disease progression based on: our preliminary studies indicating the ability of Vpr to dysregulate antigen
presenting cells and T cells directly at the cellular and molecular level, the ability of Vpr to compromise
adaptive immune response through APC-T cell cross talk, and impair the function of NK cell function and
effector molecules. Furthermore, the significance of Vpr in pathogenesis is further bolstered by the recent
study indicating the presence of free Vpr in infected targets and uninfected bystander cells in vivo. Together
these studies support our hypothesis that HIV-1 Vpr alters NK cell function and innate immunity either by
directly impairing NK cells or through infected DC subsets mediated NK-DC cross talk. Thus, the major goal
of this project is: (i) to determine how Vpr affects the NK cell function and phenotypes directly in the context
of infection and exposure; (ii) to define the mechanisms and consequence of NK cell function indirectly
through Vpr impaired DC subsets via DC-NK cell cross talk; and (iii) to delineate the effect of Vpr on NK cell
receptors and signaling pathways that regulates NK cell function and innate immunity.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.
开发一种强大的基于细胞的高通量筛选方法来识别 HIV-1 病毒蛋白 R 二聚化的靶标。
DOI:
10.2147/dddt.s44139
发表时间:
2013
期刊:
Drug design, development and therapy
影响因子:
--
作者:
[Zych,Courtney, Domling,Alexander, Ayyavoo,Velpandi]
通讯作者:
Ayyavoo,Velpandi
Modeling HIV-1 Neuropathogenesis and neuronal dysregulation using 3D-organoids containing multiple CNS cell lineages
-
批准号:10651458
-
项目类别:
-
资助金额:$68.63万
-
财政年份:2022
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8432453
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:7929088
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8619524
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8041009
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8220888
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
Project 3
-
批准号:7507623
-
项目类别:
-
资助金额:$15.73万
-
财政年份:2007
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6627836
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6496565
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6875678
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6722806
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6791675
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
NOVEL VECTOR DESIGN TO EXPRESS MULTIPLE ANTIGENS
-
批准号:6374714
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2000
-
负责人:VELPANDI AYYAVOO
-
依托单位:
NOVEL VECTOR DESIGN TO EXPRESS MULTIPLE ANTIGENS
-
批准号:6339775
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2000
-
负责人:VELPANDI AYYAVOO
-
依托单位:
Project 3
-
批准号:7671236
-
项目类别:
-
资助金额:$20.03万
-
财政年份:--
-
负责人:VELPANDI AYYAVOO
-
依托单位:
海外基金